Display options
Cite
Shah S, Karathanasi A, Revythis A, et al. Cancer-Associated Thrombosis: A New Light on an Old Story. Diseases. 2021;9(2)doi: 10.3390/diseases9020034.
Shah, S., Karathanasi, A., Revythis, A., Ioannidou, E., & Boussios, S. (2021). Cancer-Associated Thrombosis: A New Light on an Old Story. Diseases (Basel, Switzerland), 9(2), . https://doi.org/10.3390/diseases9020034
Shah, Sidrah, et al. "Cancer-Associated Thrombosis: A New Light on an Old Story." Diseases (Basel, Switzerland) vol. 9,2 (2021). doi: https://doi.org/10.3390/diseases9020034
Shah S, Karathanasi A, Revythis A, Ioannidou E, Boussios S. Cancer-Associated Thrombosis: A New Light on an Old Story. Diseases. 2021 May 04;9(2). doi: 10.3390/diseases9020034. PMID: 34064390; PMCID: PMC8161803.
Copy Download .nbib Format: NLM
Share it on

Diseases. 2021 May 04;9(2). doi: 10.3390/diseases9020034.

Cancer-Associated Thrombosis: A New Light on an Old Story.

Diseases (Basel, Switzerland)

Sidrah Shah, Afroditi Karathanasi, Antonios Revythis, Evangelia Ioannidou, Stergios Boussios

Affiliations

  1. Department of Hematology/Medical Oncology, Medway NHS Foundation Trust, Windmill Road, Gillingham ME7 5NY, UK.
  2. Department of Paediatrics and Child Health, West Suffolk Hospital NHS Foundation Trust, Hardwick Lane, Bury St Edmunds IP33 2QZ, UK.
  3. Faculty of Life Sciences & Medicine, School of Cancer & Pharmaceutical Sciences, King's College London, London SE1 9RT, UK.
  4. AELIA Organization, 9th Km Thessaloniki-Thermi, 57001 Thessaloniki, Greece.

PMID: 34064390 PMCID: PMC8161803 DOI: 10.3390/diseases9020034

Abstract

Cancer-associated thrombosis (CAT) is a rising and significant phenomenon, becoming the second leading cause of death in cancer patients. Pathophysiology of CAT differs from thrombosis in the non-cancer population. There are additional risk factors for thrombosis specific to cancer including cancer type, histology, and treatment, such as chemotherapy. Recently developed scoring systems use these risk factors to stratify the degree of risk and encourage thromboprophylaxis in intermediate- to high-risk patients. Anticoagulation is safely used for prophylaxis and treatment of CAT. Both of these have largely been with low-molecular-weight heparin (LMWH), rather than the vitamin K antagonist (VKA); however, there has been increasing evidence for direct oral anticoagulant (DOAC) use. Consequently, international guidelines have also adapted to recommend the role of DOACs in CAT. Using DOACs is a turning point for CAT, but further research is warranted for their long-term risk profile. This review will discuss mechanisms, risk factors, prophylaxis and management of CAT, including both LMWH and DOACs. There will also be a comparison of current international guidelines and how they reflect the growing evidence base.

Keywords: cancer; direct oral anticoagulant; heparins; thromboembolism; thrombosis

References

  1. Cancers (Basel). 2019 Jan 15;11(1): - PubMed
  2. BMJ. 2008 May 31;336(7655):1227-31 - PubMed
  3. Arterioscler Thromb Vasc Biol. 2019 Sep;39(9):1724-1738 - PubMed
  4. Thromb J. 2019 Jan 25;17:2 - PubMed
  5. J Thromb Haemost. 2019 Nov;17(11):1898-1911 - PubMed
  6. Asian J Surg. 2018 May;41(3):197-202 - PubMed
  7. J Thromb Haemost. 2020 Apr;18(4):905-915 - PubMed
  8. J Clin Oncol. 2007 Dec 1;25(34):5490-505 - PubMed
  9. Lancet Oncol. 2009 Oct;10(10):943-9 - PubMed
  10. Blood. 2010 Dec 9;116(24):5377-82 - PubMed
  11. J Clin Oncol. 2018 Jul 10;36(20):2017-2023 - PubMed
  12. Cardiovasc Res. 1999 Jan;41(1):21-4 - PubMed
  13. Crit Rev Oncol Hematol. 2017 May;113:83-89 - PubMed
  14. Br J Cancer. 2010 Jan 5;102(1):73-9 - PubMed
  15. Minerva Med. 2013 Apr;104(2):161-7 - PubMed
  16. Gastrointest Endosc. 2002 Feb;55(2):239-40 - PubMed
  17. Ann Oncol. 2011 Sep;22 Suppl 6:vi85-92 - PubMed
  18. Blood. 2008 May 15;111(10):4902-7 - PubMed
  19. Blood. 1998 Jul 1;92(1):143-51 - PubMed
  20. Cancer Invest. 2009;27 Suppl 1:63-74 - PubMed
  21. Arterioscler Thromb Vasc Biol. 2004 Jun;24(6):1015-22 - PubMed
  22. Blood. 2017 Mar 9;129(10):1357-1367 - PubMed
  23. Lancet Oncol. 2019 Oct;20(10):e566-e581 - PubMed
  24. Arch Intern Med. 2004 Aug 9-23;164(15):1653-61 - PubMed
  25. Cancer Metastasis Rev. 2014 Mar;33(1):231-69 - PubMed
  26. Cancer. 2020 Apr 15;126(8):1736-1748 - PubMed
  27. J Thromb Haemost. 2007 Mar;5(3):632-4 - PubMed
  28. Hematology Am Soc Hematol Educ Program. 2013;2013:684-91 - PubMed
  29. J Clin Oncol. 2020 Feb 10;38(5):496-520 - PubMed
  30. J Clin Oncol. 2009 Oct 10;27(29):4839-47 - PubMed
  31. Haematologica. 2016 Jul;101(7):e277-9 - PubMed
  32. N Engl J Med. 2019 Feb 21;380(8):711-719 - PubMed
  33. J Thromb Haemost. 2006 Mar;4(3):529-35 - PubMed
  34. N Engl J Med. 2012 Feb 16;366(7):601-9 - PubMed
  35. J Exp Med. 2012 Apr 9;209(4):819-35 - PubMed
  36. JAMA. 2015 Aug 18;314(7):677-686 - PubMed
  37. Blood. 2007 Sep 15;110(6):1723-9 - PubMed
  38. Best Pract Res Clin Haematol. 2009 Mar;22(1):49-60 - PubMed
  39. Cochrane Database Syst Rev. 2012 Feb 15;(2):CD008500 - PubMed
  40. Pharmacotherapy. 2002 Sep;22(9):1200-4 - PubMed
  41. J Exp Med. 2009 Aug 31;206(9):1913-27 - PubMed
  42. J Thromb Haemost. 2015 Jun;13(6):1028-35 - PubMed
  43. Postgrad Med J. 2007 Nov;83(985):671-4 - PubMed
  44. N Engl J Med. 2002 Mar 28;346(13):975-80 - PubMed
  45. Cancer Res. 2006 Nov 15;66(22):10643-6 - PubMed
  46. Expert Rev Hematol. 2012 Apr;5(2):201-9 - PubMed
  47. Thromb Res. 2017 Feb;150:30-32 - PubMed
  48. Thromb Haemost. 1992 Oct 5;68(4):392-5 - PubMed
  49. Clin Appl Thromb Hemost. 2020 Jan-Dec;26:1076029620954282 - PubMed
  50. Oncogene. 2000 Sep 21;19(40):4611-20 - PubMed
  51. Arch Intern Med. 2000 Mar 27;160(6):809-15 - PubMed
  52. Cancer. 2007 Nov 15;110(10):2339-46 - PubMed
  53. Ann Oncol. 2000;11 Suppl 3:273-6 - PubMed
  54. Br J Haematol. 2005 Feb;128(3):291-302 - PubMed
  55. Oncologist. 2021 Jan;26(1):e24-e40 - PubMed
  56. Arch Intern Med. 2006 Feb 27;166(4):458-64 - PubMed
  57. J Transl Med. 2005 Sep 30;3:37 - PubMed
  58. Blood. 2013 Oct 3;122(14):2310-7 - PubMed
  59. Haemostasis. 1994 Mar-Apr;24(2):128-31 - PubMed
  60. Oncoimmunology. 2013 Feb 1;2(2):e22946 - PubMed
  61. J Cardiovasc Pharmacol. 1995;25 Suppl 2:S13-9 - PubMed
  62. N Engl J Med. 2018 Feb 15;378(7):615-624 - PubMed
  63. J Clin Invest. 2003 Sep;112(6):853-62 - PubMed
  64. Strahlenther Onkol. 2004 Feb;180(2):109-16 - PubMed
  65. J Thromb Haemost. 2014 Oct;12(10):1746-9 - PubMed
  66. Thromb Res. 2016 Dec;148:63-69 - PubMed
  67. Front Cardiovasc Med. 2017 Nov 07;4:67 - PubMed
  68. JAMA. 2005 Feb 9;293(6):715-22 - PubMed
  69. Haematologica. 1993 Sep-Oct;78(5):282-6 - PubMed
  70. N Engl J Med. 2020 Apr 23;382(17):1599-1607 - PubMed
  71. J Thromb Haemost. 2005 Dec;3(12):2664-70 - PubMed
  72. Ann Surg. 2006 Jan;243(1):89-95 - PubMed
  73. Dis Colon Rectum. 2009 Mar;52(3):446-51 - PubMed
  74. J Cardiol. 2018 Aug;72(2):89-93 - PubMed
  75. Haematologica. 2000 Sep;85(9):967-72 - PubMed
  76. Pharmacol Rev. 2016 Jan;68(1):76-141 - PubMed
  77. Circulation. 2012 Feb 14;125(6):837-9 - PubMed
  78. N Engl J Med. 2008 Jan 3;358(1):36-46 - PubMed
  79. J Thromb Haemost. 2015 Jun;13(6):998-1003 - PubMed
  80. J Thromb Haemost. 2008 Apr;6(4):601-8 - PubMed
  81. Horm Cancer. 2020 Feb;11(1):13-16 - PubMed
  82. Leukemia. 2008 Feb;22(2):414-23 - PubMed
  83. Br J Surg. 1997 Aug;84(8):1099-103 - PubMed
  84. FASEB J. 1992 May;6(8):2561-7 - PubMed
  85. Circ Res. 2001 Mar 2;88(4):438-42 - PubMed
  86. Sci Rep. 2017 Jul 11;7(1):5149 - PubMed
  87. Cancer Metastasis Rev. 2000;19(1-2):93-6 - PubMed
  88. J Clin Oncol. 2006 Jan 20;24(3):484-90 - PubMed
  89. Am J Clin Oncol. 2020 Feb;43(2):94-100 - PubMed
  90. Cancers (Basel). 2018 Oct 11;10(10): - PubMed
  91. Clin Med Insights Oncol. 2014 Dec 04;8:129-37 - PubMed
  92. Blood. 2002 Nov 15;100(10):3484-8 - PubMed
  93. J Thromb Haemost. 2012 May;10(5):807-14 - PubMed
  94. Anticancer Res. 2020 Jan;40(1):305-313 - PubMed
  95. Clin Cancer Res. 2009 Nov 15;15(22):6830-40 - PubMed
  96. Thromb J. 2018 Mar 1;16:2 - PubMed
  97. J Thromb Haemost. 2018 Mar;16(3):508-518 - PubMed
  98. Haematologica. 2017 Sep;102(9):1494-1501 - PubMed
  99. BMJ Open. 2020 Nov 19;10(11):e039057 - PubMed
  100. Lancet. 2008 Feb 2;371(9610):387-94 - PubMed
  101. Chest. 2003 Sep;124(3 Suppl):26S-32S - PubMed
  102. Arch Intern Med. 2002 Aug 12-26;162(15):1729-35 - PubMed
  103. Crit Rev Clin Lab Sci. 2016 Dec;53(6):409-30 - PubMed
  104. Intern Emerg Med. 2012 Jun;7(3):291-2 - PubMed
  105. N Engl J Med. 2003 Jul 10;349(2):146-53 - PubMed
  106. Clin Cancer Res. 2007 May 15;13(10):2870-5 - PubMed
  107. Eur Respir Rev. 2019 Mar 27;28(151): - PubMed
  108. Ann Oncol. 2009 Oct;20(10):1619-30 - PubMed
  109. J Clin Oncol. 2009 Sep 1;27(25):4124-9 - PubMed
  110. Int J Gynecol Cancer. 2017 Nov;27(9):1970-1978 - PubMed
  111. Thromb Res. 2012 Mar;129(3):250-6 - PubMed
  112. Int J Gynecol Cancer. 2011 May;21(4):616-24 - PubMed
  113. Front Cell Dev Biol. 2017 Jan 05;4:147 - PubMed
  114. Int J Mol Sci. 2019 Jun 25;20(12): - PubMed

Publication Types